Intelesens
Sensor Solutions Enhancing Healthcare Delivery.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| GBP | 2016 | 2017 | 2018 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 40 % | (3 %) |
| EBITDA | 0000 | 0000 | 0000 |
| % EBITDA margin | (116 %) | (65 %) | (77 %) |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | (135 %) | (73 %) | (94 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 50 % | 29 % |
Source: Company filings or news article
Related Content
Intelesens specializes in the manufacturing of defibrillator and ECG electrodes, catering to both EU and international markets. With over two decades of experience, the company has established itself as a reliable provider in the medical device industry. Founded in Belfast, Northern Ireland, Intelesens was co-founded by a technologist who pioneered the use of defibrillators outside hospital settings. The company operates a comprehensive production facility, research and development department, and logistics center. Intelesens focuses on developing and manufacturing a variety of electrode types based on customer requirements, aiming to support products that save lives. The business model revolves around direct sales to healthcare providers and partnerships with medical device companies, generating revenue through the sale of specialized electrodes.
Keywords: defibrillator, ECG, electrodes, manufacturing, healthcare, Belfast, international, production, R&D, logistics